Tolfenamic acid is a nonsteroidal anti-inflammatory drug with neuroprotective properties, and it alleviates learning and memory deficits in the APP transgenic mouse model of Alzheimer's disease. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.